BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3895826)

  • 21. Therapeutic outcome of primary aldosteronism: adrenalectomy versus enucleation of aldosterone-producing adenoma.
    Nakada T; Kubota Y; Sasagawa I; Yagisawa T; Watanabe M; Ishigooka M
    J Urol; 1995 Jun; 153(6):1775-80. PubMed ID: 7752314
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of oral potassium on urinary kallikrein excretion in essential hypertension.
    Murakami E; Hiwada K; Kokubu T; Imamura Y
    Adv Exp Med Biol; 1989; 247B():133-7. PubMed ID: 2610052
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urinary tetrahydroaldosterone as a screening method for primary aldosteronism: a comparative study.
    Abdelhamid S; Blomer R; Hommel G; Haack D; Lewicka S; Fiegel P; Krumme B
    Am J Hypertens; 2003 Jul; 16(7):522-30. PubMed ID: 12850384
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased urinary kallikrein excretion in young borderline hypertensive patients.
    Ando K; Fujita T
    Clin Exp Hypertens A; 1983; 5(6):903-18. PubMed ID: 6349868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Studies on kallikrein-kinin system in essential hypertension: urinary kallikrein-kinin system and renin-angiotensin-aldosterone system (author's transl)].
    Abe K; Irokawa N; Seino M; Sakurai Y; Yasujima M; Chiba S; Ito T; Saito K; Miyazaki S; Imai Y; Kusaka T; Ritz K; Sato M; Haruyama T; Otsuka Y; Yoshinaga K; Saito T
    Nihon Naika Gakkai Zasshi; 1978 May; 67(5):483-94. PubMed ID: 670775
    [No Abstract]   [Full Text] [Related]  

  • 26. Relationships among urinary kallikrein, mineralocorticoids and human hypertensive disease.
    Margolius HS; Horwitz D; Pisano JJ; Keiser HR
    Fed Proc; 1976 Feb; 35(2):203-6. PubMed ID: 1248655
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urinary kallikrein excretion in hypertensive man. Relationships to sodium intake and sodium-retaining steroids.
    Margolius HS; Horwitz D; Pisano JJ; Keiser HR
    Circ Res; 1974 Dec; 35(6):820-5. PubMed ID: 4430079
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of glucocorticoid administration on aldosterone excretion and plasma renin in normal subjects, in essential hypertension and in primary aldosteronism.
    Newton MA; Laragh JH
    J Clin Endocrinol Metab; 1968 Jul; 28(7):1014-22. PubMed ID: 4298943
    [No Abstract]   [Full Text] [Related]  

  • 29. Excretion of human urinary kallikrein quantity measured by a direct radioimmunoassay of human urinary kallikrein in patients with essential hypertension and secondary hypertensive diseases.
    Shimamoto K; Ura N; Tanaka S; Ogasawara A; Nakao T; Nakahashi Y; Chao J; Margolius HS; Iimura O
    Jpn Circ J; 1981 Sep; 45(9):1092-7. PubMed ID: 6913609
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outpatient screening tests for primary aldosteronism.
    Dunn PJ; Espiner EA
    Aust N Z J Med; 1976 Apr; 6(2):131-5. PubMed ID: 1067811
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of dietary potassium and race on urinary excretion of kallikrein and aldosterone in man.
    Horwitz D; Margolius HS; Keiser HR
    J Clin Endocrinol Metab; 1978 Aug; 47(2):296-9. PubMed ID: 263797
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A case of normotensive primary aldosteronism--comparison with 13 previously experienced cases with hypertension.
    Nishimiya T; Kikuchi K; Oimatsu H; Ota S; Nakamura Y; Shimamoto K; Iimura O
    Endocrinol Jpn; 1984 Apr; 31(2):159-64. PubMed ID: 6378608
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of primary aldosteronism by the 6-hour integrated aldosterone/renin ratio.
    Zadik Z; Levin PA; Hamilton BP; Kowarski AA
    Hypertension; 1986 Apr; 8(4):285-9. PubMed ID: 3514448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of metoprolol on 24-hour urinary excretion of adrenal steroids and kallikrein in patients with essential hypertension.
    Fritschka E; Gotzen R; Kittler R; Schöneshöfer M
    Br J Pharmacol; 1984 Feb; 81(2):245-53. PubMed ID: 6367871
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of indomethacin on urinary kallikrein excretion in Bartter's syndrome of the adult.
    Lechi A; Mantero F; Opocher G; Armanini D; Lechi C; Covi G
    J Endocrinol Invest; 1981; 4(1):17-20. PubMed ID: 7016967
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma and tissue kallikrein-kinin systems during acute administration of frusemide in normotensive and hypertensive humans.
    Ohman KP; Karlberg BE
    Clin Sci (Lond); 1991 Sep; 81(3):305-11. PubMed ID: 1655330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of corticotropin on aldosterone excretion and plasma renin in normal subjects, in essential hypertension and in primary aldosteronism.
    Newton MA; Laragh JH
    J Clin Endocrinol Metab; 1968 Jul; 28(7):1006-13. PubMed ID: 4298942
    [No Abstract]   [Full Text] [Related]  

  • 38. Unilateral adrenalectomy improves urinary protein excretion but does not abolish its relationship to sodium excretion in patients with aldosterone-producing adenoma.
    Pimenta E; Gordon RD; Ahmed AH; Cowley D; Robson D; Kogovsek C; Stowasser M
    J Hum Hypertens; 2011 Oct; 25(10):592-9. PubMed ID: 21068764
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bartter's syndrome: urinary prostaglandin E-like material and kallikrein; indomethacin effects.
    Halushka PV; Wohltmann H; Privitera PJ; Hurwitz G; Margolius HS
    Ann Intern Med; 1977 Sep; 87(3):281-6. PubMed ID: 900671
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DOCA test for aldosteronism: its usefulness and implications.
    Rodríguez JA; Lopez JM; Biglieri EG
    Hypertension; 1981; 3(6 Pt 2):II-102-6. PubMed ID: 7028610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.